Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,425 results that match your search.22,425 results
  • A decision by the European Court of Justice could undermine the language regime of Community trade marks (CTMs), leading to extra costs and possible delays.
  • Sam Mamudi, Chicago
  • The EU could accede to the Madrid Protocol within a year, if the Council of Ministers adopts a proposal made last month.
  • The last few years have seen an earnest push by the Singapore government to develop the biotechnology sector in this island city-state. Indeed, biotechnology was to be the fourth pillar of the country's economy. The Straits Times recently reported that the government is spending US$1.7 billion over a period of five years to attract foreign biotech and pharmaceutical companies to Singapore.
  • In highly competitive branches of industries, it is not unusual that an imitator makes use of the unprotected part of an invention as described in an original application of a previously granted patent by marketing a product lying out of the scope of protection. Since the imitator is not obliged to pay compensation for doing this, the patentee tries to seek protection for such subject matter that is not covered by the claims of the patent.
  • The new system of resolving domain name disputes in Hong Kong is a great improvement on the old method. Domain name owners can now make use of a quicker and cheaper way to assert their rights, explain Christopher Tung and Minny Siu
  • ? US: The Department of Commerce has agreed to extend its memorandum of understanding with ICANN for three years, and to include several specific targets to help with its privatization. The agreement was due to expire at the end of this September, but will now run until September 30 2006.
  • Stéphanie Bodoni, London
  • Brian Ager, Director General, European Federation of Pharmaceutical Industries and Associations
  • A hallmark of Intellectual Property Rights (IPRs) is that they are negative in nature. Although often described as "exclusive", IPRs entitle the owner only to prevent others using or misusing the subject of the right. A recent example is provided in the field of trade marks by Inter Lotto (UK) Ltd v Camelot Group plc [2003] EWCA Civ 1132.